Medical/Pharmaceuticals
Innovent Announces Clinical Data of Multiple Trials Will be Presented at the AACR Annual Meeting 2023
ROCKVILLE, Md. and SUZHOU, China, March 21, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology ...
2023-03-21 08:00
5249
Sirnaomics to Present Latest Developments in Polypeptide Nanoparticle Platform at the 4th Annual RNAi-Based Therapeutics Summit
HONG KONG and GERMANTOWN, Md. and SUZHOU BIOBAY, China, March 20, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, and together with its subsidiaries, the"Group" or "Sirnaomics"), a leading biopharmaceutical company in the discovery and development of advanced RNAi thera...
2023-03-20 23:27
3869
Transcenta Holding Limited (6628.HK) to Hold 2022 Annual Results Release Conference Call
SUZHOU, China, March 20, 2023 /PRNewswire/ -- The management team of Transcenta Holding Limited (06628.HK) will attend the 2022 annual results release conference call onMarch 31, 2023. Transcenta is a clinical stage biopharmaceutical company with fully integrated capabilities in the discovery, r...
2023-03-20 21:12
2804
Building Back: Helping Young People Go from Recovery to Discovery
Outward Bound International releases timely and relevant report about the role of outdoor learning in addressing youth mental health and helping young people build back post pandemic. NEW YORK, March 20, 2023 /PRNewswire/ -- Outward Bound International, the coordinating organization for Outward ...
2023-03-20 21:00
2473
Guo Guangchang Stresses Healthy Corporate Development and Expresses Full Confidence in the Future
HONG KONG, March 20, 2023 /PRNewswire/ -- On 17 and 18 March, Guo Guangchang, Chairman of Fosun International, attended the 23rd Annual Conference of Yabuli China Entrepreneurs Forum 2023, and the 6th Shanghai Forum Themed Zhejiang Entrepreneurs in the World & the 11th Member Representative Confe...
2023-03-20 17:12
3459
ETANA HAS SECURED FINANCING FROM DEG, EAST VENTURES AND OTHER GLOBAL INVESTORS
JAKARTA, Indonesia, March 20, 2023 /PRNewswire/ -- PT Etana Biotechnologies Indonesia (Etana), an Indonesian biopharmaceutical company, has secured a new round of investment led by DEG followed by Yunfeng Capital, HighLight Capital and East Ventures. This round of financing will be used for fu...
2023-03-20 15:22
4451
Antengene Announces Five Upcoming Presentations at the 2023 American Association for Cancer Research Annual Meeting
– Five posters will showcase progress with multiple preclinical and clinical programs, including the clinical results ofATG-008 (mTORC1/2 inhibitor) and preclinical data ofATG-031 (anti-CD24 monoclonal antibody), ATG-037 (small molecule CD73 inhibitor), ATG-017 (ERK1/2 inhibitor), and ATG-034 (L...
2023-03-20 15:20
2835
Agilis Robotics has kickstarted its first trial in mainland China, taking a great leap forward in robotized endoscopic surgery in the country
HONG KONG, March 20, 2023 /PRNewswire/ -- Agilis Robotics is a company that is revolutionizing the world of endoscopic surgery. The company has developed the world's smallest flexible and dexterous endoscopic robot system, which is a breakthrough in the field of robotics surgery. The Agilis Robo...
2023-03-20 14:30
3366
Innovating for better sleep
BEIJING, March 20, 2023 /PRNewswire/ -- Sleep is essential for health. Like eating well and exercising, sleep is a behavior that is essential to a person's physical, mental, and social well-being. However, sleep is not yet universally recognized as an essential behavior for physical health.1 BMC...
2023-03-20 10:00
3302
320 World Oral Health Day - Lifting the "mask mandate", maintaining good oral hygiene and flashing a healthy and confident smile.
HONG KONG, March 20, 2023 /PRNewswire/ -- According to a report released by the World Health Organization (WHO) in 2022, oral diseases are the most common non-communicable diseases in humans and affect 3.5 billion people worldwide. Approximately 2 billion people have untreated caries in permanent...
2023-03-20 09:00
969
AffaMed Technologies Announces TFDA Approval of MINI WELL, MINI WELL PROXA, MINI WELL TORIC and MINI 4 Ready IOLs for Cataract Treatment in Taiwan
SHANGHAI, March 20, 2023 /PRNewswire/ -- AffaMed Technologies, a joint venture established between AffaMed Therapeutics and SIFI S.p.A., today announced that the Taiwan Food and Drug Administration ("TFDA") has approved its MINI WELL, MINI WELL PROXA, MINI WELL TORIC and MINI 4 Ready intraocular ...
2023-03-20 09:00
4589
Izokibep Phase 2b/3 Hidradenitis Suppurative Data Presented at the 2023 American Academy of Dermatology Annual Meeting
* At 12 weeks, participants achieved high orders of HiSCR responses (HiSCR75 and above), including 33% achieving HiSCR100. * Safety results were consistent with previous trials of izokibep and the IL-17Ai class, with no increased risk of infection, including candida. SAN DIEGO ,SHANGHAI and SY...
2023-03-20 08:41
4091
AMGEN AND NSG BIOLABS ANNOUNCE ALBATROZ THERAPEUTICS AS WINNER OF FIRST AMGEN GOLDEN TICKET IN SINGAPORE
The Golden Ticket will help to boost the biotech startup's capabilities and to develop further the emerging biotech ecosystem inSoutheast Asia SINGAPORE, March 20, 2023 /PRNewswire/ -- Leading global biotechnology company Amgen and NSG BioLabs,Singapore's largest and leading provider of biotechn...
2023-03-20 08:00
3854
Sisram Medical Ltd. to Announce Full Year 2022 Financial Results on March 21, 2023
Conference call to be held on March 22, 2023, at 8:00 a.m. Eastern Time HONG KONG, March 17, 2023 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram",stock code: 1696.HK; together with its subsidiaries referred as the "Group"), a global consumer wellness group featuring a first-of-its-k...
2023-03-17 19:04
5545
China's first personalized neoantigen-targeted cancer vaccine receives NMPA's clinical trial approval
BEIJING, March 17, 2023 /PRNewswire/ -- According the latest data released at the Clinical Trials Implied Approval section on the website ofChina's Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA), Likang Life Sciences (hereinafter referred to as "Likang") h...
2023-03-17 14:56
2740
YS BIOPHARMA TO RING THE OPENING BELL AND DEBUT ON NASDAQ
YS Biopharma Ordinary Shares and Warrants to Trade on the Nasdaq Under Tickers "YS" and "YSBPW" NEW YORK, March 17, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (the "Company" or "YS Biopharma"), a global biopharmaceutical company focusing on new generations of vaccines and therapeutic biologic...
2023-03-17 04:30
3158
Bolstering Healthcare Quality in Malaysia with Renowned Flagship Hospitals
Malaysia's position as a safe and trusted destination for high-quality healthcare services is reinforced with the debut of flagship medical tourism hospitals in the country. KUALA LUMPUR, Malaysia, March 16, 2023 /PRNewswire/ -- Malaysia has debuted its first-of-its-kind Flagship Medical Tourism...
2023-03-16 16:12
6164
The FDA has approved the CSF-1R inhibitor Pimicotinib (ABSK021) of Abbisko Therapeutics to enter the Pivotal Global Multi-center Phase III Clinical Trial
This is the first-ever global phase III trial for TGCT approved by NMPA and FDA. Pimicotinib（ABSK021）was granted BTD by FDA and CDE, discovered and developed byChina biotech。 SHANGHAI, March 16, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. (HKEX Stock Code: 2256. HK, referred to as "Abbis...
2023-03-16 10:00
5829
Alphamab Oncology Announces the First Patient Dosed in the Phase I Trial of Anti-HER2 bispecific ADC JSKN003
SUZHOU, China, March 16, 2023 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been dosed with 2.1mg/kg in a Phase I clinical study (JSKN003-102) of JSKN003, an Anti-HER2 bispecific ADC. ADC drugs have the advantages of highly specific targeting of anti...
2023-03-16 09:58
3464
FDA Approves Expanded Indication for Telix's Illuccix® to Include Patient Selection for PSMA-Directed Radioligand Therapy
MELBOURNE, Australia, March 16, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States Food and Drug Administration (FDA) has approved a supplementary New Drug Application (sNDA) for Illuccix® (kit for the preparation of gallium Ga...
2023-03-16 08:28
3303
Week's Top Stories
Most Reposted
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
[Picked up by 310 media titles]
2026-10-13 10:00
Agoda and Emerging Travel Group Enter Strategic Partnership
[Picked up by 292 media titles]
2026-10-15 16:00Food & Hospitality Asia 2027 Redefining Excellence: The Premier Platform for Food & Beverage and Hospitality Innovation
[Picked up by 281 media titles]
2026-10-15 10:00Leading Asian DMC Discova to Attend ITB Asia 2026
[Picked up by 279 media titles]
2026-10-15 12:59
DayOne Upsizes Malaysia Financing to US$7.2 Billion; Total Billings Surpass 1GW and Bookings Reach 2.3GW
[Picked up by 270 media titles]
2026-10-14 18:01Most Read
Amap and Sands China mark the delivery of the first Tutu robots, with expected indoor navigation and 3D resort previews
2026-10-10 16:43
16160
Sonilo Raises $11M to Build the AI-Native Audio Stack for Video
2026-10-15 00:00
15382
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
2026-10-13 10:00
13592
Zoomlion Expands Mining Machinery Business as International Revenue Grows
2026-10-10 16:58
7720
